Collectively, these multivariable findings support a 2-step clinical strategy: selecting the agent with the best GI tolerability profile for the individual patient, then anticipating long term persistence issues, chiefly in IBS-M and publicly insured populations (Fig
This study is examining weight loss, appetite suppression, and HbA1C changes, which are the primary outcomes of interest for a GLP-1 agonist
Ploder M, Kurz K, Spittler A, Neurauter G, Roth E, Fuchs D
The result is cholesterol-saturated bile sitting in a relatively inactive gallbladder, which promotes crystal and stone formation
These categories matter in compliance: These go through Phases I-III clinical trials, get reviewed, and are approved for specific indications and doses
Studies show that oxidative stress is the main cause of hair loss and graying